Sigma has updated one of its key prime lenses, making a 35mm F1.4 that's smaller, lighter and faster than its predecessor. It ...

Sigma’s newest lenses, the full-frame 35mm f/1.4 DG II Art lens and the 15mm f/1.4 DC Contemporary lens for APS-C cameras.NEW YORK, ...

A hidden donor-recipient HLA mismatch may increase the risk of life-threatening immune complications after cord blood ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Tevogen.AI reports improved PredicTcell™ beta accuracy, expanding its peptide database and AI platform to accelerate drug ...

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...

Matrigel is the most commonly used biomaterial for bioengineering tissues from hPSCs. However, its origins from mouse sarcoma come with significant drawbacks, including poor definability, ...

Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aims to harness, direct and optimize their immune suppressive properties to address serious ...

Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized shares, including placement through the ATM, over the next ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

Many MS genetic risk factors are shared across ancestral backgrounds, but European-focused studies may miss others, per a study.